home

clinical

diabetes

Clinical

Dr. Schachter specializes in ocular surface disease and serves as a Vision Source administrator for central California coast. He serves on the advisory board for Allergan, BlephEx, Sun Pharma, and ScienceBased Health, and he is a speaker for Allergan, Bau

Articles

Medical optometry and comprehensive eye care

Dr. Ferrucci is Chief of optometry at the Sepulveda VA, as well as a professor at the Southern California College of Optometry. He currently serves on the advisory board for Maculogix.

Faricimab shows promise in treating diabetic macular edema
and age-related macular degeneration

Pipeline: Potential new therapy coming for macular disease

Dr. Mohammad Rafieetary is a consultative optometric physician at the Charles Retina Institute in Memphis. He is a fellow of the American Academy of Optometry and a Diplomate of the American Board of Optometry as well as the American Board of Certificatio

• Relatable patient education improves quality of care and prognosis
 
• Although patients with moderate NPDR without DME can be followed every 6 to 9 months, when macular involvement is present patient needs more frequent follow-up

• Patients with diabetic retinopathy need to be informed about importance of follow-up care even in the absence of their vision changes


Diabetes

Medical optometry and comprehensive eye care

Pipeline: Potential new therapy coming for macular disease

Patient education vs patient relations?